- Home
- AXSM vs RGC Comparison
AXSM vs RGC Comparison
Compare AXSM & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | RGC |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 11.5B |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AXSM | RGC |
|---|---|---|
| Price | $236.31 | $5.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $211.12 | N/A |
| AVG Volume (30 Days) | ★ 878.2K | 568.6K |
| Earning Date | 05-04-2026 | 10-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $57.24 | N/A |
| Revenue Next Year | $55.88 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $96.09 | $4.92 |
| 52 Week High | $260.19 | $69.00 |
Technical Indicators
Market Signals| Indicator | AXSM | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 47.92 | 25.33 |
| Support Level | $236.44 | N/A |
| Resistance Level | $256.40 | $25.78 |
| Average True Range (ATR) | 9.67 | 1.30 |
| MACD | -2.09 | 0.37 |
| Stochastic Oscillator | 42.72 | 5.80 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.